C07F 9/4087
Esters with arylalkanols
Official title: {Esters with arylalkanols}
C07F9/4087 (Esters with arylalkanols) appears on 47 US grants and 20 published applications in this corpus.
Search patents in C07F- Granted patents
- 47
- Published applications
- 20
- Assignees
- 36
- Inventors
- 101
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 3 |
| 2010 | 0 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 3 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Prodrugs of prostate specific membrane antigen (PSMA) inhibitor19 Mar 2024US 11,932,664 B2Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- One-step synthesis of phosphate-based inhibitors and applications thereof17 Jan 2023US 11,555,047 B2North Carolina State University
- Prodrugs of prostate specific membrane antigen (PSMA) inhibitor10 May 2022US 11,325,931 B2Inst of Organic Chem. and Biochemistry AS CR V.V.I
- Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates23 Feb 2021US 10,927,135 B2The Board of Regents of the Nevada System of Higher Education On Behalf of the University of Nevada, Las Vegas
- Prodrugs of prostate specific membrane antigen (PSMA) inhibitor28 Jan 2020US 10,544,176 B2The Johns Hopkins University
- Phosphorus-containing (meth)acryloyl compound, phosphorus-containing vinyl benzyl compound, production methods therefor, flame-retardant resin composition and laminated board for electronic circuit board containing same6 Aug 2026US 2026/0226082 A1Nippon Steel Chemical & Material Co., Ltd.
- Prodrugs of prostate specific membrane antigen (psma) inhibitor13 Apr 2023US 2023/0115651 A1Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- One-Step Synthesis of Phosphate-Based Inhibitors and Applications Thereof6 May 2021US 2021/0130381 A1North Carolina State University
- Prodrugs of prostate specific membrane antigen (psma) inhibitor24 Dec 2020US 2020/0399298 A1Institute of Organic Chemistry and Biochemistry of the AS CR, V.V.I.
- Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates13 Aug 2020US 2020/0255461 A1Board of Regents of the Nevada System of Higher Education, on behalf of the University of Nevada
Most cited
By later US patents
- Phosphorous prodrugs and therapeutic delivery systems using same102US 5,627,165 ADrug Innovation & Design, Inc. · 1997
- Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof56US 6,927,036 B2Xero Port, Inc. · 2005
- Targeted drug delivery via phosphonate derivatives55US 5,177,064 AUniversity of Florida · 1993
- Targeted drug delivery via phosphonate derivatives53US 5,413,996 AUniversity of Florida · 1995
- Phosphonomonoester nucleic acids, process for their preparation, and their use33US 5,874,553 AHoechst Aktiengesellschaft · 1999